992 related articles for article (PubMed ID: 25692314)
1. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
2. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
[TBL] [Abstract][Full Text] [Related]
3. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of the effect of spray drying and hot-melt extrusion on the properties of amorphous solid dispersions containing felodipine.
Mahmah O; Tabbakh R; Kelly A; Paradkar A
J Pharm Pharmacol; 2014 Feb; 66(2):275-84. PubMed ID: 24433426
[TBL] [Abstract][Full Text] [Related]
5. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine.
Konno H; Handa T; Alonzo DE; Taylor LS
Eur J Pharm Biopharm; 2008 Oct; 70(2):493-9. PubMed ID: 18577451
[TBL] [Abstract][Full Text] [Related]
6. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
[TBL] [Abstract][Full Text] [Related]
7. Optimising Drug Solubilisation in Amorphous Polymer Dispersions: Rational Selection of Hot-melt Extrusion Processing Parameters.
Li S; Tian Y; Jones DS; Andrews GP
AAPS PharmSciTech; 2016 Feb; 17(1):200-13. PubMed ID: 26729536
[TBL] [Abstract][Full Text] [Related]
8. Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders.
Keen JM; Martin C; Machado A; Sandhu H; McGinity JW; DiNunzio JC
J Pharm Pharmacol; 2014 Feb; 66(2):204-17. PubMed ID: 24433423
[TBL] [Abstract][Full Text] [Related]
9. Screen for Inhibitors of Crystal Growth to Identify Desirable Carriers for Amorphous Solid Dispersions Containing Felodipine.
Fu J; Cui L; Yang C; Xiong H; Ren G; Ma X; Jing Q; Ren F
AAPS PharmSciTech; 2018 Apr; 19(3):1231-1242. PubMed ID: 29302871
[TBL] [Abstract][Full Text] [Related]
10. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
[TBL] [Abstract][Full Text] [Related]
11. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
[TBL] [Abstract][Full Text] [Related]
12. Impact of Polymer Enrichment at the Crystal-Liquid Interface on Crystallization Kinetics of Amorphous Solid Dispersions.
Zhang J; Shi Q; Tao J; Peng Y; Cai T
Mol Pharm; 2019 Mar; 16(3):1385-1396. PubMed ID: 30716277
[TBL] [Abstract][Full Text] [Related]
13. Effects of polymer type and storage relative humidity on the kinetics of felodipine crystallization from amorphous solid dispersions.
Rumondor AC; Stanford LA; Taylor LS
Pharm Res; 2009 Dec; 26(12):2599-606. PubMed ID: 19806435
[TBL] [Abstract][Full Text] [Related]
14. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
15. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
Dukeck R; Sieger P; Karmwar P
Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
[TBL] [Abstract][Full Text] [Related]
16. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
Konno H; Taylor LS
J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
[TBL] [Abstract][Full Text] [Related]
17. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
18. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
[TBL] [Abstract][Full Text] [Related]
19. Effect of polymer hygroscopicity on the phase behavior of amorphous solid dispersions in the presence of moisture.
Rumondor AC; Taylor LS
Mol Pharm; 2010 Apr; 7(2):477-90. PubMed ID: 20039693
[TBL] [Abstract][Full Text] [Related]
20. Real time Raman imaging to understand dissolution performance of amorphous solid dispersions.
Tres F; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
J Control Release; 2014 Aug; 188():53-60. PubMed ID: 24910191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
